Lawmakers led by Rep. Greg Murphy, MD, R-N.C., are reintroducing the Provider Reimbursement Stability Act of 2026, which is endorsed by the AMA and MGMA.
U.K.-based Lucida Medical’s diagnostic tool is already deployed by the NHS, with the company earmarking the funds for the pursuit of regulatory approval in the U.S.
Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.
New findings from a large CT lung cancer screening dataset reveal that a substantial number of patients have significant incidental findings visible on their scans.
Lipoprotein (a) research is on the rise in recent years. Deepak Bhatt, MD, director of Mount Sinai Fuster Heart Hospital, explains why this trend is so important.
“Radiology, by nature, presents a unique challenge to physician well-being,” Cody R. Johnson, MD, and colleagues write in Current Problems in Diagnostic Radiology.
According to the Wall Street Journal, the DOJ is looking into whether the insurer is responsible for billing the Centers for Medicare & Medicaid Services for patient diagnoses not applicable to the actual care a patient will need, in an effort to boost monthly payments received by the agency.
Ctexli (chenodiol) can now be prescribed to patients with cerebrotendinous xanthomatosis, a condition caused by a genetic mutation that leads to cholesterol buildup around vital organs.
Lawmakers led by Rep. Greg Murphy, MD, R-N.C., are reintroducing the Provider Reimbursement Stability Act of 2026, which is endorsed by the AMA and MGMA.
